48,868
edits
Line 80: | Line 80: | ||
*TFE3 -ve. | *TFE3 -ve. | ||
**By definition +ve in [[Xp11.2 translocation carcinoma]]. | **By definition +ve in [[Xp11.2 translocation carcinoma]]. | ||
*AMACR -ve. | *[[AMACR]] -ve. | ||
**Usu. +ve in [[Papillary RCC]]. | **Usu. +ve in [[Papillary RCC]]. | ||
*Smooth muscle actin +ve (focal).<ref name=pmid23238627>{{Cite journal | last1 = Williamson | first1 = SR. | last2 = Eble | first2 = JN. | last3 = Cheng | first3 = L. | last4 = Grignon | first4 = DJ. | title = Clear cell papillary renal cell carcinoma: differential diagnosis and extended immunohistochemical profile. | journal = Mod Pathol | volume = 26 | issue = 5 | pages = 697-708 | month = May | year = 2013 | doi = 10.1038/modpathol.2012.204 | PMID = 23238627 }}</ref> | *Smooth muscle actin +ve (focal).<ref name=pmid23238627>{{Cite journal | last1 = Williamson | first1 = SR. | last2 = Eble | first2 = JN. | last3 = Cheng | first3 = L. | last4 = Grignon | first4 = DJ. | title = Clear cell papillary renal cell carcinoma: differential diagnosis and extended immunohistochemical profile. | journal = Mod Pathol | volume = 26 | issue = 5 | pages = 697-708 | month = May | year = 2013 | doi = 10.1038/modpathol.2012.204 | PMID = 23238627 }}</ref> |
edits